

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.71809276 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.71809276 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.71809276 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.71809276 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.71809276 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.71809276 |
| 7 | microglial cell activation (GO:0001774) | 4.78145125 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.40434588 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 4.16749923 |
| 10 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.12216509 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.03913289 |
| 12 | * endothelium development (GO:0003158) | 3.79665047 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74195685 |
| 14 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.71220705 |
| 15 | negative regulation of adherens junction organization (GO:1903392) | 3.62171915 |
| 16 | negative regulation of focal adhesion assembly (GO:0051895) | 3.62171915 |
| 17 | negative regulation of cell junction assembly (GO:1901889) | 3.62171915 |
| 18 | regulation of mononuclear cell migration (GO:0071675) | 3.57729152 |
| 19 | response to peptidoglycan (GO:0032494) | 3.56229907 |
| 20 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.51165763 |
| 21 | activation of MAPKKK activity (GO:0000185) | 3.49176785 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46288772 |
| 23 | response to host immune response (GO:0052572) | 3.46288772 |
| 24 | angiogenesis involved in wound healing (GO:0060055) | 3.45427828 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.37361111 |
| 26 | positive regulation of heat generation (GO:0031652) | 3.35935942 |
| 27 | response to host (GO:0075136) | 3.34433114 |
| 28 | response to host defenses (GO:0052200) | 3.34433114 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.34433114 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29432861 |
| 31 | endothelial tube morphogenesis (GO:0061154) | 3.28671885 |
| 32 | morphogenesis of an endothelium (GO:0003159) | 3.28671885 |
| 33 | macrophage activation (GO:0042116) | 3.28071772 |
| 34 | establishment of endothelial barrier (GO:0061028) | 3.26144929 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 3.24710235 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 3.23020905 |
| 37 | positive regulation of vasculogenesis (GO:2001214) | 3.22827093 |
| 38 | positive regulation of macrophage cytokine production (GO:0060907) | 3.22489013 |
| 39 | regulation of fever generation (GO:0031620) | 3.21647785 |
| 40 | protein localization to endosome (GO:0036010) | 3.19489366 |
| 41 | regulation of podosome assembly (GO:0071801) | 3.17848024 |
| 42 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.11930457 |
| 43 | I-kappaB phosphorylation (GO:0007252) | 3.06547308 |
| 44 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.05892191 |
| 45 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.04831483 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.03528840 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02162242 |
| 48 | positive regulation of receptor recycling (GO:0001921) | 2.99441773 |
| 49 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.97573307 |
| 50 | lymph vessel development (GO:0001945) | 2.93252925 |
| 51 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93097093 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 2.92293530 |
| 53 | apoptotic cell clearance (GO:0043277) | 2.90878464 |
| 54 | stress fiber assembly (GO:0043149) | 2.89160560 |
| 55 | regulation of early endosome to late endosome transport (GO:2000641) | 2.86763201 |
| 56 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.86664125 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85052657 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84509506 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 2.83481941 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.83189541 |
| 61 | growth hormone receptor signaling pathway (GO:0060396) | 2.82614951 |
| 62 | barbed-end actin filament capping (GO:0051016) | 2.82446539 |
| 63 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.81594653 |
| 64 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.81282629 |
| 65 | regulation of vasculogenesis (GO:2001212) | 2.79441118 |
| 66 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.78412599 |
| 67 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.77906631 |
| 68 | surfactant homeostasis (GO:0043129) | 2.76960322 |
| 69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74426151 |
| 70 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.73158109 |
| 71 | regulation of integrin activation (GO:0033623) | 2.72444582 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.71313717 |
| 73 | regulation of cholesterol storage (GO:0010885) | 2.71178458 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71061781 |
| 75 | regulation of chemokine biosynthetic process (GO:0045073) | 2.70676454 |
| 76 | Notch signaling involved in heart development (GO:0061314) | 2.69243953 |
| 77 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.68758309 |
| 78 | pinocytosis (GO:0006907) | 2.68613292 |
| 79 | germinal center formation (GO:0002467) | 2.68236497 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67319244 |
| 81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67185697 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.66678676 |
| 83 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.65383414 |
| 84 | regulation of macrophage chemotaxis (GO:0010758) | 2.63354845 |
| 85 | positive regulation of odontogenesis (GO:0042482) | 2.63186255 |
| 86 | positive regulation of p38MAPK cascade (GO:1900745) | 2.62127066 |
| 87 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.61919828 |
| 88 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.61715193 |
| 89 | response to magnesium ion (GO:0032026) | 2.61518251 |
| 90 | germ cell migration (GO:0008354) | 2.59771813 |
| 91 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59189569 |
| 92 | epithelial cell-cell adhesion (GO:0090136) | 2.58407994 |
| 93 | glomerular visceral epithelial cell development (GO:0072015) | 2.58081986 |
| 94 | basement membrane organization (GO:0071711) | 2.56596835 |
| 95 | hyaluronan catabolic process (GO:0030214) | 2.56363875 |
| 96 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56248161 |
| 97 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.56229696 |
| 98 | * substrate-dependent cell migration (GO:0006929) | 2.56061927 |
| 99 | regulation of chronic inflammatory response (GO:0002676) | 2.55401041 |
| 100 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55200198 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.54967225 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 2.54545334 |
| 103 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54143624 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.53765511 |
| 105 | regulation of macrophage cytokine production (GO:0010935) | 2.53648858 |
| 106 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.53628198 |
| 107 | endothelial cell morphogenesis (GO:0001886) | 2.52776408 |
| 108 | modulation by symbiont of host cellular process (GO:0044068) | 2.51399418 |
| 109 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.51131744 |
| 110 | glycosphingolipid catabolic process (GO:0046479) | 2.50885807 |
| 111 | plasma membrane repair (GO:0001778) | 2.50674654 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.49754500 |
| 113 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.49751425 |
| 114 | virion attachment to host cell (GO:0019062) | 2.48777807 |
| 115 | adhesion of symbiont to host cell (GO:0044650) | 2.48777807 |
| 116 | endocytic recycling (GO:0032456) | 2.48740165 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46862439 |
| 118 | mRNA transcription (GO:0009299) | 2.46694728 |
| 119 | Rap protein signal transduction (GO:0032486) | 2.46239789 |
| 120 | negative regulation of cell killing (GO:0031342) | 2.46141791 |
| 121 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46141791 |
| 122 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.45760326 |
| 123 | T-helper 1 type immune response (GO:0042088) | 2.45498477 |
| 124 | regulation of endothelial cell differentiation (GO:0045601) | 2.43596110 |
| 125 | endothelial cell chemotaxis (GO:0035767) | 2.42724796 |
| 126 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42515403 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41734347 |
| 128 | patterning of blood vessels (GO:0001569) | 2.41515690 |
| 129 | lymphangiogenesis (GO:0001946) | 2.40727712 |
| 130 | negative regulation of interleukin-17 production (GO:0032700) | 2.40557672 |
| 131 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40220794 |
| 132 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.40115363 |
| 133 | regulation of gamma-delta T cell activation (GO:0046643) | 2.40045670 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39796294 |
| 135 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.38837325 |
| 136 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.38700557 |
| 137 | regulation of p38MAPK cascade (GO:1900744) | 2.38480357 |
| 138 | cellular response to growth hormone stimulus (GO:0071378) | 2.38093044 |
| 139 | hemidesmosome assembly (GO:0031581) | 2.37353793 |
| 140 | adhesion of symbiont to host (GO:0044406) | 2.36204376 |
| 141 | negative regulation of lipid storage (GO:0010888) | 2.35519831 |
| 142 | ovulation from ovarian follicle (GO:0001542) | 2.35498563 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35321065 |
| 144 | response to progesterone (GO:0032570) | 2.34594577 |
| 145 | blood vessel endothelial cell migration (GO:0043534) | 2.34547789 |
| 146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33372946 |
| 147 | response to fluid shear stress (GO:0034405) | 2.32766934 |
| 148 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.32707995 |
| 149 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.32561130 |
| 150 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.32368078 |
| 151 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.32356608 |
| 152 | regulation of heat generation (GO:0031650) | 2.31720240 |
| 153 | cell-substrate junction assembly (GO:0007044) | 2.30950618 |
| 154 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.30403278 |
| 155 | glomerular epithelial cell development (GO:0072310) | 2.29758111 |
| 156 | cellular response to lipopolysaccharide (GO:0071222) | 2.27741276 |
| 157 | membrane raft organization (GO:0031579) | 2.27474066 |
| 158 | semaphorin-plexin signaling pathway (GO:0071526) | 2.26486782 |
| 159 | adherens junction assembly (GO:0034333) | 2.26337044 |
| 160 | positive regulation of extracellular matrix organization (GO:1903055) | 2.26109522 |
| 161 | blood vessel maturation (GO:0001955) | 2.25732550 |
| 162 | neuron remodeling (GO:0016322) | 2.24802431 |
| 163 | immunoglobulin mediated immune response (GO:0016064) | 2.24767067 |
| 164 | wound healing, spreading of cells (GO:0044319) | 2.24341478 |
| 165 | positive regulation of astrocyte differentiation (GO:0048711) | 2.22426493 |
| 166 | monocyte differentiation (GO:0030224) | 2.21995039 |
| 167 | regulation of T cell tolerance induction (GO:0002664) | 2.21878844 |
| 168 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.21575098 |
| 169 | granulocyte activation (GO:0036230) | 2.21136034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.33747774 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.30949403 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.07604798 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25106519 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20879838 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83246068 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65243069 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64180650 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56089931 |
| 10 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.54975408 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.32848553 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31260253 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.25765370 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24599472 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19577814 |
| 16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17869620 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15607116 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10417454 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10357746 |
| 20 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10289113 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00171220 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99684605 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94174389 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89485996 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89169540 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80858956 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78573430 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74854653 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73898701 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71646902 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71312271 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69511063 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67067581 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66181724 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66106388 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59656508 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56069354 |
| 38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51615841 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48339355 |
| 40 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.47489438 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46718991 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.46419915 |
| 43 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43541001 |
| 44 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42870127 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42418508 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.42139652 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40477937 |
| 48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37612742 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37095115 |
| 50 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36251707 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36251707 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35571164 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35061738 |
| 54 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33194248 |
| 55 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33194248 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32016923 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31729800 |
| 58 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31420795 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29829283 |
| 60 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29015958 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28361957 |
| 62 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.26936596 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26358406 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26180150 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25762448 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25683770 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25325698 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24091719 |
| 69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22810861 |
| 70 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22069372 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21612013 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21508594 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21209357 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21026847 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20770812 |
| 76 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20745116 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20549014 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20223024 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18314154 |
| 80 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17728954 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17599281 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14944343 |
| 83 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14498706 |
| 84 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14064185 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12333288 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11945716 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11908264 |
| 88 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10943050 |
| 89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10485977 |
| 90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09480169 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.08568555 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07933941 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07495816 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07099217 |
| 95 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06849446 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06793124 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05748952 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05550473 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04488129 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04141511 |
| 101 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04121185 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03924044 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02989634 |
| 104 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.02928360 |
| 105 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02755358 |
| 106 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02712467 |
| 107 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02712467 |
| 108 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02712467 |
| 109 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02507878 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02414693 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02309169 |
| 112 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.01491674 |
| 113 | MYB_26560356_Chip-Seq_TH2_Human | 1.01189048 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00517828 |
| 115 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00194914 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00187513 |
| 117 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00043122 |
| 118 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99782103 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99747750 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98675773 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97779660 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97662351 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96987393 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96779704 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96300127 |
| 126 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95862408 |
| 127 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.95782607 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95646171 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95370047 |
| 130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94832042 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94738256 |
| 132 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93492739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.65601950 |
| 2 | * MP0005167_abnormal_blood-brain_barrier | 3.16187683 |
| 3 | MP0010368_abnormal_lymphatic_system | 3.07431677 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.01223518 |
| 5 | MP0001879_abnormal_lymphatic_vessel | 2.88014900 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.75946564 |
| 7 | MP0004510_myositis | 2.69382953 |
| 8 | MP0003828_pulmonary_edema | 2.63818789 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.42578844 |
| 10 | MP0003436_decreased_susceptibility_to | 2.41832936 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.32830992 |
| 12 | MP0003724_increased_susceptibility_to | 2.26378851 |
| 13 | MP0005451_abnormal_body_composition | 2.20077522 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.19188898 |
| 15 | MP0004272_abnormal_basement_membrane | 2.10210458 |
| 16 | MP0006082_CNS_inflammation | 2.06810479 |
| 17 | MP0009785_altered_susceptibility_to | 2.00945404 |
| 18 | MP0000343_altered_response_to | 1.94071164 |
| 19 | MP0003091_abnormal_cell_migration | 1.94064986 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.92439754 |
| 21 | MP0009278_abnormal_bone_marrow | 1.92334506 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.80647005 |
| 23 | MP0003075_altered_response_to | 1.76790216 |
| 24 | MP0008004_abnormal_stomach_pH | 1.76204074 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.73543044 |
| 26 | MP0002419_abnormal_innate_immunity | 1.73401965 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.70994905 |
| 28 | MP0005387_immune_system_phenotype | 1.70164818 |
| 29 | MP0001790_abnormal_immune_system | 1.70164818 |
| 30 | MP0004233_abnormal_muscle_weight | 1.66795353 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.64244533 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.64053888 |
| 33 | MP0003448_altered_tumor_morphology | 1.62666071 |
| 34 | * MP0000767_abnormal_smooth_muscle | 1.61579509 |
| 35 | MP0005409_darkened_coat_color | 1.59824555 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.57298042 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.56224677 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.56224677 |
| 39 | MP0005671_abnormal_response_to | 1.55957049 |
| 40 | MP0000685_abnormal_immune_system | 1.54937526 |
| 41 | MP0005165_increased_susceptibility_to | 1.53748305 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.50702636 |
| 43 | MP0001849_ear_inflammation | 1.50198157 |
| 44 | MP0001853_heart_inflammation | 1.49653392 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.48655625 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.48235450 |
| 47 | MP0005595_abnormal_vascular_smooth | 1.43610971 |
| 48 | MP0005025_abnormal_response_to | 1.42841585 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.42748836 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.42102708 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.42037824 |
| 52 | MP0004130_abnormal_muscle_cell | 1.40682349 |
| 53 | MP0003045_fibrosis | 1.37675621 |
| 54 | MP0006054_spinal_hemorrhage | 1.36917597 |
| 55 | * MP0000249_abnormal_blood_vessel | 1.36290629 |
| 56 | MP0002723_abnormal_immune_serum | 1.34951883 |
| 57 | MP0001800_abnormal_humoral_immune | 1.31887900 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.28600005 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.28508781 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.27440918 |
| 61 | MP0001958_emphysema | 1.27260662 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.27193169 |
| 63 | MP0005023_abnormal_wound_healing | 1.26855425 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.26200451 |
| 65 | MP0001819_abnormal_immune_cell | 1.23525323 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.23339441 |
| 67 | MP0002796_impaired_skin_barrier | 1.22121763 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.21724049 |
| 69 | MP0002405_respiratory_system_inflammati | 1.21653170 |
| 70 | MP0000751_myopathy | 1.21278765 |
| 71 | MP0002420_abnormal_adaptive_immunity | 1.20782223 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.20551301 |
| 73 | * MP0001544_abnormal_cardiovascular_syste | 1.19392485 |
| 74 | * MP0005385_cardiovascular_system_phenoty | 1.19392485 |
| 75 | MP0005623_abnormal_meninges_morphology | 1.19292784 |
| 76 | MP0002933_joint_inflammation | 1.17733436 |
| 77 | MP0005166_decreased_susceptibility_to | 1.16987483 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.16325542 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.16247341 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.15908490 |
| 81 | MP0009840_abnormal_foam_cell | 1.15296912 |
| 82 | MP0010630_abnormal_cardiac_muscle | 1.14118637 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.13372123 |
| 84 | MP0004947_skin_inflammation | 1.12676946 |
| 85 | MP0005330_cardiomyopathy | 1.11268195 |
| 86 | MP0001851_eye_inflammation | 1.10713691 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 1.09686227 |
| 88 | MP0002254_reproductive_system_inflammat | 1.09335165 |
| 89 | MP0008775_abnormal_heart_ventricle | 1.08987629 |
| 90 | MP0008260_abnormal_autophagy | 1.06344092 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 1.06234589 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.04859689 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 1.04814626 |
| 94 | MP0002925_abnormal_cardiovascular_devel | 1.03083182 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.01482063 |
| 96 | MP0004484_altered_response_of | 1.00408096 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.97913351 |
| 98 | * MP0003279_aneurysm | 0.96953678 |
| 99 | * MP0001614_abnormal_blood_vessel | 0.95753221 |
| 100 | MP0008469_abnormal_protein_level | 0.95457557 |
| 101 | * MP0002128_abnormal_blood_circulation | 0.94773700 |
| 102 | MP0002928_abnormal_bile_duct | 0.94544693 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.93338377 |
| 104 | MP0003690_abnormal_glial_cell | 0.91488822 |
| 105 | MP0000604_amyloidosis | 0.91403876 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.90398191 |
| 107 | * MP0006138_congestive_heart_failure | 0.89938791 |
| 108 | MP0000733_abnormal_muscle_development | 0.89122478 |
| 109 | MP0004858_abnormal_nervous_system | 0.88638567 |
| 110 | MP0000749_muscle_degeneration | 0.88468003 |
| 111 | MP0008438_abnormal_cutaneous_collagen | 0.88219635 |
| 112 | MP0003941_abnormal_skin_development | 0.87188863 |
| 113 | MP0000858_altered_metastatic_potential | 0.87183118 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.85913931 |
| 115 | MP0009764_decreased_sensitivity_to | 0.85572812 |
| 116 | MP0005164_abnormal_response_to | 0.84611661 |
| 117 | MP0005257_abnormal_intraocular_pressure | 0.84059668 |
| 118 | MP0002006_tumorigenesis | 0.83518697 |
| 119 | MP0005670_abnormal_white_adipose | 0.83390664 |
| 120 | MP0008874_decreased_physiological_sensi | 0.81033371 |
| 121 | * MP0001915_intracranial_hemorrhage | 0.79639665 |
| 122 | MP0005390_skeleton_phenotype | 0.78768510 |
| 123 | MP0003329_amyloid_beta_deposits | 0.78424826 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.78322997 |
| 125 | MP0001727_abnormal_embryo_implantation | 0.74900271 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.71473869 |
| 127 | MP0000747_muscle_weakness | 0.71151837 |
| 128 | MP0004883_abnormal_blood_vessel | 0.66697899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 5.20262893 |
| 2 | Cerebral aneurysm (HP:0004944) | 4.20999932 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 4.14790636 |
| 4 | Polycythemia (HP:0001901) | 4.00379920 |
| 5 | Nuclear cataract (HP:0100018) | 3.84723205 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.83531228 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.79266166 |
| 8 | Esophageal varix (HP:0002040) | 3.78694461 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.51750208 |
| 10 | Spontaneous hematomas (HP:0007420) | 3.40118798 |
| 11 | Arterial tortuosity (HP:0005116) | 3.36996675 |
| 12 | Myocardial infarction (HP:0001658) | 3.35387177 |
| 13 | Glomerulonephritis (HP:0000099) | 3.29329258 |
| 14 | Loss of speech (HP:0002371) | 3.29142230 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.21312412 |
| 16 | Axonal loss (HP:0003447) | 3.13000931 |
| 17 | Interstitial pulmonary disease (HP:0006530) | 3.09741527 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07034529 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07034529 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07034529 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.07028232 |
| 22 | Increased connective tissue (HP:0009025) | 3.04586761 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04394162 |
| 24 | Vascular tortuosity (HP:0004948) | 3.00605391 |
| 25 | Muscle fiber splitting (HP:0003555) | 2.89806078 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87121956 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87121956 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87121956 |
| 29 | Urethral obstruction (HP:0000796) | 2.79796225 |
| 30 | Aortic aneurysm (HP:0004942) | 2.73780527 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.73574343 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.70274100 |
| 33 | Nephritis (HP:0000123) | 2.68161340 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.66395753 |
| 35 | J-shaped sella turcica (HP:0002680) | 2.60562368 |
| 36 | Disinhibition (HP:0000734) | 2.59301351 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.57875229 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.56124655 |
| 39 | Sudden death (HP:0001699) | 2.53402375 |
| 40 | Thick nail (HP:0001805) | 2.47990269 |
| 41 | Difficulty climbing stairs (HP:0003551) | 2.45999066 |
| 42 | Colitis (HP:0002583) | 2.44933446 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.42868791 |
| 44 | Ventricular tachycardia (HP:0004756) | 2.41263121 |
| 45 | Cervical subluxation (HP:0003308) | 2.41019764 |
| 46 | Mucosal telangiectasiae (HP:0100579) | 2.35761894 |
| 47 | Cerebral hemorrhage (HP:0001342) | 2.34963336 |
| 48 | Osteolytic defects of the hand bones (HP:0009699) | 2.33539166 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33539166 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.32647240 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.31563463 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.31266067 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.29931780 |
| 54 | Tetraparesis (HP:0002273) | 2.29595935 |
| 55 | Spinal rigidity (HP:0003306) | 2.28194847 |
| 56 | Bulbar palsy (HP:0001283) | 2.28165930 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.26541312 |
| 58 | Menorrhagia (HP:0000132) | 2.26516862 |
| 59 | Mitral valve prolapse (HP:0001634) | 2.24832418 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.23165382 |
| 61 | Camptodactyly of toe (HP:0001836) | 2.22415149 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21768321 |
| 63 | Stroke (HP:0001297) | 2.21572820 |
| 64 | Bicuspid aortic valve (HP:0001647) | 2.21074423 |
| 65 | Difficulty running (HP:0009046) | 2.20720785 |
| 66 | Fatigue (HP:0012378) | 2.20287085 |
| 67 | Striae distensae (HP:0001065) | 2.18923533 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.18744590 |
| 69 | Purpura (HP:0000979) | 2.18021823 |
| 70 | Frequent falls (HP:0002359) | 2.16834634 |
| 71 | Exercise-induced muscle cramps (HP:0003710) | 2.15976877 |
| 72 | Thin bony cortex (HP:0002753) | 2.15588545 |
| 73 | Mutism (HP:0002300) | 2.14973852 |
| 74 | Conjunctival telangiectasia (HP:0000524) | 2.13681260 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.13432785 |
| 76 | Broad face (HP:0000283) | 2.10947559 |
| 77 | Xerostomia (HP:0000217) | 2.09530179 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.09318775 |
| 79 | Aneurysm (HP:0002617) | 2.08237667 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08032787 |
| 81 | Adactyly (HP:0009776) | 2.06995260 |
| 82 | Rapidly progressive (HP:0003678) | 2.06843817 |
| 83 | Flat acetabular roof (HP:0003180) | 2.05148903 |
| 84 | Milia (HP:0001056) | 2.03799679 |
| 85 | Porencephaly (HP:0002132) | 2.03529980 |
| 86 | Absent hand (HP:0004050) | 2.02940405 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02435915 |
| 88 | Right ventricular cardiomyopathy (HP:0011663) | 2.02158187 |
| 89 | Lymphangioma (HP:0100764) | 2.01707234 |
| 90 | Skull defect (HP:0001362) | 2.01436824 |
| 91 | Gingivitis (HP:0000230) | 2.00330545 |
| 92 | Pulmonary infiltrates (HP:0002113) | 1.99737655 |
| 93 | Persistence of primary teeth (HP:0006335) | 1.99048023 |
| 94 | Complement deficiency (HP:0004431) | 1.98237218 |
| 95 | Amyloidosis (HP:0011034) | 1.98129036 |
| 96 | EMG: myopathic abnormalities (HP:0003458) | 1.96898460 |
| 97 | Stomatitis (HP:0010280) | 1.96636913 |
| 98 | Increased serum ferritin (HP:0003281) | 1.96425881 |
| 99 | Myositis (HP:0100614) | 1.95736814 |
| 100 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95705448 |
| 101 | Facial diplegia (HP:0001349) | 1.95338453 |
| 102 | Scapular winging (HP:0003691) | 1.93484348 |
| 103 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.93277582 |
| 104 | Neonatal death (HP:0003811) | 1.92856320 |
| 105 | Subaortic stenosis (HP:0001682) | 1.92853233 |
| 106 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.92853233 |
| 107 | Achilles tendon contracture (HP:0001771) | 1.92770506 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.91651435 |
| 109 | Disproportionate tall stature (HP:0001519) | 1.91365173 |
| 110 | Arterial thrombosis (HP:0004420) | 1.90773120 |
| 111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89877062 |
| 112 | Joint contractures involving the joints of the feet (HP:0100492) | 1.89482870 |
| 113 | Flexion contracture of toe (HP:0005830) | 1.89482870 |
| 114 | Polygenic inheritance (HP:0010982) | 1.89108285 |
| 115 | Aortic dissection (HP:0002647) | 1.88775581 |
| 116 | Premature rupture of membranes (HP:0001788) | 1.88360134 |
| 117 | Recurrent fungal infections (HP:0002841) | 1.87937805 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.87828861 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.86207747 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 1.85653544 |
| 121 | Wrist flexion contracture (HP:0001239) | 1.85453570 |
| 122 | Orchitis (HP:0100796) | 1.83499922 |
| 123 | Bone cyst (HP:0012062) | 1.83363518 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.82989353 |
| 125 | Abnormal platelet function (HP:0011869) | 1.82989353 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.82097548 |
| 127 | Prolonged neonatal jaundice (HP:0006579) | 1.80684540 |
| 128 | Atrial fibrillation (HP:0005110) | 1.80442521 |
| 129 | Portal hypertension (HP:0001409) | 1.79316981 |
| 130 | Increased density of long bones (HP:0006392) | 1.78996301 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.78803802 |
| 132 | Visceral angiomatosis (HP:0100761) | 1.78770060 |
| 133 | Pulmonary hypertension (HP:0002092) | 1.78506632 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.78429516 |
| 135 | Upper limb amyotrophy (HP:0009129) | 1.78429516 |
| 136 | Joint stiffness (HP:0001387) | 1.78305564 |
| 137 | Abnormality of complement system (HP:0005339) | 1.77309714 |
| 138 | Lower limb amyotrophy (HP:0007210) | 1.77295142 |
| 139 | Hyperparathyroidism (HP:0000843) | 1.75383898 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.75307112 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.74458810 |
| 142 | Joint hemorrhage (HP:0005261) | 1.73900365 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.73363238 |
| 144 | Epistaxis (HP:0000421) | 1.71547304 |
| 145 | Bone pain (HP:0002653) | 1.70918599 |
| 146 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.69046860 |
| 147 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67001151 |
| 148 | Abnormality of the hepatic vasculature (HP:0006707) | 1.66763250 |
| 149 | Hemangiomatosis (HP:0007461) | 1.62294449 |
| 150 | Diaphragmatic weakness (HP:0009113) | 1.61207603 |
| 151 | Pathologic fracture (HP:0002756) | 1.60484431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.05162508 |
| 2 | TIE1 | 4.12918923 |
| 3 | TTN | 3.50919004 |
| 4 | RIPK1 | 3.27292012 |
| 5 | MAP3K14 | 2.76638187 |
| 6 | KDR | 2.67795946 |
| 7 | TRIB3 | 2.44811547 |
| 8 | TBK1 | 2.24405831 |
| 9 | DDR2 | 2.17818165 |
| 10 | PAK4 | 2.14471019 |
| 11 | TYK2 | 2.14393583 |
| 12 | EPHB1 | 2.03102240 |
| 13 | TAOK2 | 1.95917386 |
| 14 | PKN2 | 1.95825479 |
| 15 | MAP2K3 | 1.90621322 |
| 16 | JAK3 | 1.88065859 |
| 17 | SIK1 | 1.85654655 |
| 18 | TESK1 | 1.83206782 |
| 19 | PTK6 | 1.81054352 |
| 20 | RIPK4 | 1.78028577 |
| 21 | MAP4K1 | 1.76360911 |
| 22 | DMPK | 1.74309727 |
| 23 | LATS2 | 1.69741902 |
| 24 | PTK2B | 1.61039877 |
| 25 | MAP3K3 | 1.55909955 |
| 26 | EPHA2 | 1.44242489 |
| 27 | ERN1 | 1.43553095 |
| 28 | IRAK3 | 1.42789654 |
| 29 | PRPF4B | 1.40910177 |
| 30 | TGFBR1 | 1.38778368 |
| 31 | JAK1 | 1.36824956 |
| 32 | MAP3K11 | 1.36357780 |
| 33 | ZAP70 | 1.36152398 |
| 34 | CSK | 1.29339806 |
| 35 | CDC42BPA | 1.25243837 |
| 36 | ICK | 1.23518591 |
| 37 | STK10 | 1.17880182 |
| 38 | MAPK15 | 1.09205046 |
| 39 | PTK2 | 1.01839879 |
| 40 | CSF1R | 1.01096069 |
| 41 | IKBKB | 1.00574509 |
| 42 | IKBKE | 0.99812182 |
| 43 | TYRO3 | 0.96481623 |
| 44 | PDGFRA | 0.95488744 |
| 45 | MAP3K10 | 0.93872264 |
| 46 | LRRK2 | 0.93116875 |
| 47 | GRK7 | 0.92594322 |
| 48 | ABL2 | 0.92560732 |
| 49 | EPHB2 | 0.91528474 |
| 50 | CAMK1D | 0.91294048 |
| 51 | HCK | 0.91097582 |
| 52 | SMG1 | 0.90697537 |
| 53 | ARAF | 0.90393186 |
| 54 | CHUK | 0.88016600 |
| 55 | MAPK12 | 0.85487906 |
| 56 | FER | 0.83571781 |
| 57 | JAK2 | 0.81709604 |
| 58 | TAOK1 | 0.81077977 |
| 59 | MAP3K1 | 0.80314883 |
| 60 | FGFR4 | 0.78491158 |
| 61 | PRKG2 | 0.77415821 |
| 62 | RPS6KA2 | 0.77195601 |
| 63 | MARK3 | 0.76483694 |
| 64 | FES | 0.76132066 |
| 65 | MAPKAPK3 | 0.75056953 |
| 66 | IRAK4 | 0.74494344 |
| 67 | CAMK1G | 0.73682833 |
| 68 | EGFR | 0.72672446 |
| 69 | LIMK1 | 0.72241241 |
| 70 | PDGFRB | 0.72154737 |
| 71 | NTRK1 | 0.71631391 |
| 72 | FGFR3 | 0.71305765 |
| 73 | PAK2 | 0.70876642 |
| 74 | BLK | 0.70179469 |
| 75 | FGR | 0.70090573 |
| 76 | STK24 | 0.69312777 |
| 77 | NEK9 | 0.69161494 |
| 78 | SIK3 | 0.68506342 |
| 79 | IRAK2 | 0.67963372 |
| 80 | PRKD1 | 0.67697140 |
| 81 | TRPM7 | 0.66883020 |
| 82 | BMX | 0.65524717 |
| 83 | ITK | 0.65431882 |
| 84 | KIT | 0.64722239 |
| 85 | MATK | 0.64406777 |
| 86 | LCK | 0.63890609 |
| 87 | RPS6KA4 | 0.62023836 |
| 88 | GSK3A | 0.59396008 |
| 89 | MST1R | 0.58567447 |
| 90 | TSSK6 | 0.58557717 |
| 91 | DAPK3 | 0.56945878 |
| 92 | TXK | 0.56272241 |
| 93 | DAPK2 | 0.55700973 |
| 94 | MAPKAPK2 | 0.54503937 |
| 95 | MAP3K12 | 0.54043198 |
| 96 | MYLK | 0.53767001 |
| 97 | EEF2K | 0.52901952 |
| 98 | ERBB4 | 0.51572467 |
| 99 | ILK | 0.51515659 |
| 100 | PRKCH | 0.51142647 |
| 101 | CDK6 | 0.50964967 |
| 102 | PDK2 | 0.50912671 |
| 103 | MAP3K5 | 0.50687885 |
| 104 | CDK12 | 0.50007848 |
| 105 | RET | 0.49794760 |
| 106 | TESK2 | 0.48900861 |
| 107 | INSR | 0.48613521 |
| 108 | ABL1 | 0.48389158 |
| 109 | MOS | 0.47874582 |
| 110 | MAP3K9 | 0.47097176 |
| 111 | MARK2 | 0.46757872 |
| 112 | IGF1R | 0.46639398 |
| 113 | MET | 0.46610737 |
| 114 | IRAK1 | 0.45476977 |
| 115 | MAP3K13 | 0.45325080 |
| 116 | RPS6KC1 | 0.44184873 |
| 117 | RPS6KL1 | 0.44184873 |
| 118 | MTOR | 0.43544262 |
| 119 | SIK2 | 0.43185990 |
| 120 | PDPK1 | 0.43163931 |
| 121 | CAMK2G | 0.42902589 |
| 122 | NME2 | 0.42723640 |
| 123 | MAP3K7 | 0.41495318 |
| 124 | MAPK4 | 0.41311698 |
| 125 | MAP2K2 | 0.41173503 |
| 126 | CAMKK1 | 0.41074856 |
| 127 | ALK | 0.39723828 |
| 128 | SRC | 0.39416493 |
| 129 | STK3 | 0.39105632 |
| 130 | BMPR2 | 0.38633918 |
| 131 | ROCK2 | 0.38041161 |
| 132 | MUSK | 0.36688755 |
| 133 | PIM2 | 0.34467552 |
| 134 | PRKAA2 | 0.33888202 |
| 135 | PDK1 | 0.33011446 |
| 136 | PRKD3 | 0.31927136 |
| 137 | MAP3K6 | 0.31381048 |
| 138 | ROCK1 | 0.29355065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40549147 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22736352 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04722142 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93001760 |
| 5 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.87004617 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 1.76810472 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74841319 |
| 8 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.74765339 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.73399663 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71316695 |
| 11 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.66450398 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.62725304 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61868590 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56085899 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55548376 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 1.55286712 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.50400790 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.47083113 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 1.45626856 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.44733990 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44549222 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.43078141 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.42784754 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.41183388 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.39869774 |
| 26 | * Focal adhesion_Homo sapiens_hsa04510 | 1.39576646 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.36992890 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.36105562 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34488222 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29911286 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.29896603 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29895902 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26168968 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25445450 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24247953 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23687310 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23314909 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21946903 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21588553 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.20761100 |
| 41 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17978926 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17518820 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17224624 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.16794280 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16011625 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11223289 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05327019 |
| 48 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03734646 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.03392546 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.03261214 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02096083 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00892070 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99157427 |
| 54 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98569851 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98215885 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97596696 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97237102 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96324955 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95037593 |
| 60 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94904024 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94569145 |
| 62 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94538146 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93699713 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93356300 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92371566 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91407142 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.91151115 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.90718748 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90482764 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.89677051 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.89611838 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88238145 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86254995 |
| 74 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85383268 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82623662 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80881491 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79291146 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.78859666 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75437442 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75283341 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.74860395 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.73781786 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71843076 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71765395 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71390381 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68183232 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67752651 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66460281 |
| 89 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65561519 |
| 90 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.65241606 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64140205 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63686268 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62893520 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62675803 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62074594 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61426132 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61412024 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60115601 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58311737 |
| 100 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56180926 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55799355 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54685774 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54586665 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53235465 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.53192096 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52713104 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52693252 |
| 108 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52480312 |
| 109 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52376841 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.52021326 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51711406 |
| 112 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.50751035 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50481938 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49750552 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49403161 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49197021 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49022405 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48075088 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42007534 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40250991 |

